Tempe Chen
Pediatric Infectious Diseases · Long Beach, CANPI 1043368863
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,060 of the $5,555 with a category attached, or 73.1%. 19 manufacturers reported payments, led by Gilead at 28.2% of the total. Reporting peaked in 2022 at $2,085 and has fallen 83.6% since, to $343 in 2025.
Across 160 payments — averaging $34.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Partner Therapeutics, Inc.$1K
- Johnson & Johnson$841
- Viiv Healthcare Company$552
- Merck$234
- Abbott$206
- plus $797 from 13 others
Across 106 payments — averaging $714.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$51K
- Astellas US Technologies$25K
What the payments were for
- Speaking & faculty fees$1,35724%
- Food & beverage$4,06073%
- Education$1382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 48 | $1,569 |
| Partner Therapeutics, Inc. | 1 | $1,357 |
| Johnson & Johnson(2 entities) | 48 | $841 |
| Viiv Healthcare Company | 23 | $552 |
| Merck | 12 | $234 |
| Abbott | 2 | $206 |
| GSK | 1 | $120 |
| Janssen Products, LP | 2 | $110 |
| Lilly USA, LLC | 1 | $107 |
| Insmed, Inc. | 5 | $101 |
| EMD Serono, Inc. | 6 | $95 |
| AbbVie(2 entities) | 3 | $66 |
| Cook Medical LLC | 2 | $47 |
| KARL Storz Endoscopy-america | 1 | $47 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Qiagen, LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,555 in reported general payments places this provider in the 85th percentile of 83 pediatric infectious diseases providers in California.
See all pediatric infectious diseases providers in California →
Other pediatric infectious diseases in Long Beach
- Audra DeveikisLong Beach$24K
- David MichalikLong Beach$5K
- Jagmohan BatraLong Beach$5K
- Jay LiebermanLong Beach$300
- James McCartyMadera$877K
- Lashonda SpencerLos Angeles$123K
- Antonio ArrietaOrange$107K
- John BradleySan Diego$86K
- Hayley GansPalo Alto$30K
- Yvonne MaldonadoStanford$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.